Nrx Pharmaceuticals Inc (NRXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,650 | -1,488 | 273 | 408 | 423 |
| Depreciation Amortization | 18 | 17 | N/A | N/A | N/A |
| Accounts receivable | -1,254 | -314 | N/A | N/A | N/A |
| Other Working Capital | 1,342 | 200 | 116 | 5 | 80 |
| Other Operating Activity | 4,686 | 857 | -465 | -1,206 | -1,034 |
| Operating Cash Flow | $-1,858 | $-728 | $-76 | $-793 | $-531 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -193 | -993 | -854 |
| Other Investing Activity | 0 | 0 | 26,119 | 41,240 | 31,457 |
| Investing Cash Flow | $N/A | $N/A | $25,926 | $40,247 | $30,603 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 630 | 620 | 229 | 1,327 | 1,167 |
| Debt Repayment | N/A | N/A | N/A | -65 | -65 |
| Common Stock Issued | 1,589 | 177 | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | -25,998 | -40,727 | -30,991 |
| Other Financing Activity | 50 | 50 | 0 | 0 | 0 |
| Financing Cash Flow | $2,269 | $847 | $-25,769 | $-39,465 | $-29,889 |
| Beginning Cash Position | 877 | 877 | 0 | 11 | 11 |
| End Cash Position | 1,288 | 996 | 81 | 0 | 194 |
| Net Cash Flow | $410 | $119 | $81 | $-11 | $183 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,858 | -728 | -76 | -793 | -531 |
| Free Cash Flow | -1,858 | -728 | -76 | -793 | -531 |